Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesBruce Neal, David R. Matthews, Vlado Perkovic et al.|New England Journal of Medicine|2017Cited by 7.7k
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)S. E. Inzucchi, David R. Matthews|Diabetologia|2012Cited by 3.9k
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachSilvio E. Inzucchi, David R. Matthews|Diabetes Care|2012Cited by 3.2k
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Bruce Neal, Ngozi Erondu et al.|The Lancet Diabetes & Endocrinology|2018Cited by 642
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 DiabetesSophia Zoungas, Mark Woodward, John Chalmers et al.|New England Journal of Medicine|2014Cited by 624